Fusion Pharmaceuticals Inc. Operating Lease, Liability, Current
Fusion Pharmaceuticals Inc. had Operating Lease, Liability, Current of $4.29 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2024-05-07
- 2024-03-31: Operating Lease, Liability, Current $4.29M.
- 2023-12-31: Operating Lease, Liability, Current $4.16M.
- 2023-09-30: Operating Lease, Liability, Current $6.17M.
- 2023-06-30: Operating Lease, Liability, Current $5.36M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2024-03-31 | $4.29M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.16M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $6.17M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $5.36M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $4.64M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.44M 10-K · filed 2024-03-20 |
| 2022-09-30 | $1.43M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.44M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.43M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.22M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.33M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.26M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.19M 10-Q · filed 2021-05-11 |